WisdomTree
Mobeen Tahir

Mobeen Tahir

Director, Research

Mobeen is a member of WisdomTree’s research team where he focuses on a wide range of asset classes to offer strategic and tactical insights to our clients on global markets and investment products. Before joining WisdomTree in December 2018, Mobeen worked at Willis Towers Watson as an investment consultant advising institutional clients as well as their in-house fund business on asset allocation and portfolio construction with his research focus being equity and multi-asset smart beta. Mobeen has a BSc (Hons) in Accounting and Financial Management from Loughborough University and an MSc in Accounting and Finance from the London School of Economics and Political Science. He is also a CFA Charterholder.

Latest insights from Mobeen Tahir

Cybercriminals Are Winning—Cybersecurity Must Strike Back Now
2024 Superconvergence BioRevolution Series: Training the Immune System to Fight Cancer - Cover Image
Christopher Gannatti, CFA
Mobeen Tahir

Cybercriminals Are Winning—Cybersecurity Must Strike Back Now

Cybercriminals can now breach systems in just 51 seconds. As AI-powered threats rise, cybersecurity can’t afford to fall behind. Christopher Gannatti and Mobeen Tahir explore how the WisdomTree Cybersecurity Fund (WCBR) is tapping into the fast-growing market of companies securing the digital future.

Read the article

Have Commodities Hit Peak Bearishness? What Happens Next?
alternative_1.jpg
Christopher Gannatti, CFA
Mobeen Tahir

Have Commodities Hit Peak Bearishness? What Happens Next?

Investor sentiment in commodity markets appears to have reached an extreme level of bearishness, with net speculative positioning on commodity futures at its lowest point in several years. Christopher Gannatti and Mobeen Tahir delve into the various subsectors of the commodities market and discuss whether this bearishness signals an inflection point and what could come next. 

Read the article

AlphaFold 3: The Future of AI in Biotechnology Is Here
2024 Superconvergence BioRevolution Series: Training the Immune System to Fight Cancer - Cover Image
Christopher Gannatti, CFA
Mobeen Tahir

AlphaFold 3: The Future of AI in Biotechnology Is Here

Google DeepMind and Isomorphic Labs have recently unveiled an exciting new breakthrough, AlphaFold 3, an AI-powered software set to revolutionize drug discovery and enhance our understanding of molecular biology. Christopher Gannatti reviews the capabilities of AlphaFold 3, its potential impact and how investors can capitalize on the AI megatrend. 

Read the article

5 Cutting-Edge Innovations Redefining Battery Technology Right Now
battery_5.jpg
Christopher Gannatti, CFA
Mobeen Tahir

5 Cutting-Edge Innovations Redefining Battery Technology Right Now

In 1991, Sony revolutionized the tech world by commercializing the first rechargeable li-ion battery, powering a new wave of consumer electronics. Now, battery technology is on the brink of another turning point that could surpass the wonders of '91. Christopher Gannatti & Mobeen Tahir outline five innovations currently electrifying the industry. 

Read the article

GO PAPERLESS

Contact your broker to sign up for eDelivery of WisdomTree ETF documents.

Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds before investing. U.S. investors only: To obtain a prospectus containing this and other important information, please call 866.909.9473, or click here to view or download a prospectus online. Read the prospectus carefully before you invest. There are risks involved with investing, including the possible loss of principal. Past performance does not guarantee future results.

You cannot invest directly in an index.

Foreign investing involves currency, political and economic risk. Funds focusing on a single country, sector and/or funds that emphasize investments in smaller companies may experience greater price volatility. Investments in emerging markets, real estate, currency, fixed income and alternative investments include additional risks. Due to the investment strategy of certain Funds, they may make higher capital gain distributions than other ETFs. Please see prospectus for discussion of risks.

WisdomTree Funds are distributed by Foreside Fund Services, LLC, in the U.S.

© 2026 WisdomTree, Inc. All Rights Reserved.